Clene Inc

+0.05 (+3.36%)
5:20:53 PM EDT: $1.55 +0.01 (+0.65%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)113.69M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.14 Million
Adjusted EPS-$0.13
See more estimates
10-Day MA$1.53
50-Day MA$1.21
200-Day MA$2.23
See more pivots

Clene Inc Stock, NASDAQ:CLNN

6550 South Millrock Drive, Suite G50, Salt Lake City, Utah 84121
United States of America
Phone: +1.801.676.9695
Number of Employees: 102


Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development of therapeutics for neurodegenerative diseases. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. The company was founded on August 12, 2020 and is headquartered in Salt Lake City, UT.